Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
- 1 July 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 14 (9), 863-872
- https://doi.org/10.1016/s1470-2045(13)70255-9
Abstract
No abstract availableKeywords
Funding Information
- RTOG (U10 CA21661)
- Community Clinical Oncology Program (U10 CA37422)
This publication has 28 references indexed in Scilit:
- Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant ChemotherapyUrology, 2009
- Organ Preservation for Muscle-Invasive Bladder Cancer by Transurethral ResectionUrology, 2007
- Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder EraJournal of Urology, 2006
- Stage Specific Lymph Node Metastasis Mapping in Radical Cystectomy SpecimensJournal of Urology, 2004
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerThe New England Journal of Medicine, 2003
- CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIESJournal of Urology, 2001
- The randomization and stratification of patients to clinical trialsJournal of Chronic Diseases, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIALBiometrika, 1934